naropin
Generic: ropivacaine hydrochloride
Labeler: fresenius kabi usa, llcDrug Facts
Product Profile
Brand Name
naropin
Generic Name
ropivacaine hydrochloride
Labeler
fresenius kabi usa, llc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
ropivacaine hydrochloride 5 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
63323-286
Product ID
63323-286_324532ac-4e54-4659-a1a2-9ade22a1ed3f
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA020533
Listing Expiration
2026-12-31
Marketing Start
2009-08-04
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
63323286
Hyphenated Format
63323-286
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
naropin (source: ndc)
Generic Name
ropivacaine hydrochloride (source: ndc)
Application Number
NDA020533 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 mg/mL
Packaging
- 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-286-27) / 20 mL in 1 VIAL, SINGLE-DOSE (63323-286-41)
- 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-286-38) / 30 mL in 1 VIAL, SINGLE-DOSE (63323-286-43)
Packages (2)
Ingredients (1)
Linked Drug Pages (3)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["EPIDURAL", "INFILTRATION", "PERINEURAL"], "spl_id": "324532ac-4e54-4659-a1a2-9ade22a1ed3f", "openfda": {"upc": ["0363323286439", "0363323285418", "0363323286415", "0363323285593", "0363323285531"], "unii": ["V910P86109"], "rxcui": ["1734203", "1734204", "1734207", "1734208", "1734347", "1734348", "1734355", "1734356", "1734475", "1734476", "1734479", "1734480", "1734481", "1734482", "1734483", "1734484"], "spl_set_id": ["dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 CARTON (63323-286-27) / 20 mL in 1 VIAL, SINGLE-DOSE (63323-286-41)", "package_ndc": "63323-286-27", "marketing_start_date": "20090804"}, {"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 CARTON (63323-286-38) / 30 mL in 1 VIAL, SINGLE-DOSE (63323-286-43)", "package_ndc": "63323-286-38", "marketing_start_date": "20090804"}], "brand_name": "Naropin", "product_id": "63323-286_324532ac-4e54-4659-a1a2-9ade22a1ed3f", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Amide Local Anesthetic [EPC]", "Amides [CS]", "Local Anesthesia [PE]"], "product_ndc": "63323-286", "generic_name": "ROPIVACAINE HYDROCHLORIDE", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Naropin", "active_ingredients": [{"name": "ROPIVACAINE HYDROCHLORIDE", "strength": "5 mg/mL"}], "application_number": "NDA020533", "marketing_category": "NDA", "marketing_start_date": "20090804", "listing_expiration_date": "20261231"}